Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
stent implantation · 1 trial · 1 indication
Evaluate the completeness of neointimal coverage following stent implantation (everolimus vs. zotarolimus-eluting stent) in patients with ACS. The degree of neointimal coverage will be assessed using optical coherence tomography (OCT) calculating the rate of exposed stent struts in the study stents.
| Arm | Type | Description |
|---|---|---|
| everolimus | ACTIVE_COMPARATOR | everolimus-eluting stent |
| zotarolimus | ACTIVE_COMPARATOR | zotarolimus-eluting stent |
| Name | Type | Description |
|---|---|---|
| stent implantation | DEVICE | implantation of everolimus-eluting stent vs zotarolimus-eluting stent |
Inclusion Criteria: * Diagnosis of ACS and clinical indication to PCI * Presence of 1 or more de novo stenosis equal or greater than 70% in native coronary arteries. * Patient is \> 18 years of age (or minimum age as required by local regulations). * The patient has consented to participate by sign...